NeuroSense Therapeutics H1 EPS $(0.77), Down From $(0.55) YoY
Portfolio Pulse from Benzinga Newsdesk
NeuroSense Therapeutics reported a H1 EPS of $(0.77), a decrease from $(0.55) YoY.
August 16, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
NeuroSense Therapeutics' H1 EPS decreased to $(0.77) from $(0.55) YoY.
NeuroSense Therapeutics' H1 EPS has decreased year over year, which indicates a decline in profitability. This could negatively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100